Listen to the Children: How I Counsel Parents and Children With Psoriasis
  • CME

It can be challenging to care for children with psoriasis when parents are reluctant to pursue systemic therapy. In this commentary, I share how I compassionately counsel families on the pros and cons of systemic therapy options for managing pediatric psoriasis.
person default
Jim Treat, MD
Physicians: maximum of 0.25 AMA PRA Category 1 Credits
Released: January 8, 2021 Expiration: January 7, 2022

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Include patients and family in discussion of risk vs benefit of systemic therapies for moderate to severe plaque psoriasis in children so that treatment decisions align with the expectations and goals of the pediatric patient, family, and clinician.
  • Explore the unique challenges of treating plaque psoriasis in young children.

Acknowledgements

Provided by Clinical Care Options

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

This activity is supported by an educational grant from
Lilly

Information on this Educational Activity

Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any relevant conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:

Faculty

Jim Treat, MD

Associate Professor of Clinical Pediatrics and Dermatology
Perelman School of Medicine
University of Pennsylvania
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania

Jim Treat, MD, has no relevant conflicts of interest to report.

Staff

Zachary Schwartz, MSc

Scientific Director

Zachary Schwartz, MSc, ELS, has no relevant conflicts of interest to report.
Megan Cartwright, PhD

Senior Clinical Editor

Megan Cartwright, PhD, has no relevant conflicts of interest to report.
Carolyn Skowronski, PharmD

Associate Director, Scientific Services

Carolyn Skowronski, PharmD, has no relevant conflicts of interest to report.
Anne Roc, PhD
Director, Scientific Services
Anne Roc, PhD, has no relevant conflicts of interest to report.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Target Audience

This program is intended for pediatricians and dermatology and rheumatology specialists, including physicians and other healthcare providers who care for patients with psoriasis.

Goal

The goal of this activity is to improve the knowledge and competence of learners to employ recommended treatment options and patient-centered care strategies to achieve optimal clinical outcomes and patient satisfaction.

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Credit Designation

CCO designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Program Medium

This program has been made available online.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 0.25 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from January 08, 2021, through January 07, 2022:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 100% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Related Content

Video from Clinical Care Options (CCO) featuring expert insights into the whole-patient approach including treatment selection, common comorbidities, and coordination of care for patients with PsO/PsA.

April W. Armstrong, MD, MPH Philip Mease, MD, MACR Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Released: August 27, 2021 Expired: August 26, 2022

Clinical Care Options (CCO) faculty Dr. April Armstrong and Dr. Philip Mease discuss problem of access to dermatologists and rheumatologists experienced by patients with PsO and PsA and potential solutions

April W. Armstrong, MD, MPH Philip Mease, MD, MACR Released: August 20, 2021

Expert slides from Clinical Care Options (CCO) on optimal management of psoriasis (PsO) and psoriatic arthritis (PsA)

April W. Armstrong, MD, MPH Philip Mease, MD, MACR Released: July 1, 2021

CCO slides on when to use interleukins inhibitors in psoriatis arthritis: biologic dmard or MTX naive? IL-17A secukinumab, ixekizumab; IL-12/23 ustekinumab.

Vinod Chandran, MBBS, MD, DM, PhD person default Alexis Ogdie, MD, MSCE Released: December 29, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue